Akamis Bio is a biotechnology company founded in 2010. Specializing in the Biotechnology and Health Care industries, it has received a significant $30.00M investment through a Convertible Note investment in 05 January 2023. This investment comes from reputable investors such as Arch Venture Partners, Westlake Village BioPartners, and the Parker Institute for Cancer Immunotherapy.
Akamis Bio
Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer
Founded 2010
Abingdon, United Kingdom
50 employees
Convertible Note
Total: $102.70M
Biotechnology, Health Care +1
Abingdon, United Kingdom
50 employees
Convertible Note
Total: $102.70M
Biotechnology, Health Care +1
General Information
Get notified when Akamis Bio moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track Akamis Bio
Get real-time alerts for funding, hiring, news, and 40+ signal types.
See how it worksDiscover More
United Kingdom Market
Biotechnology
About Akamis Bio
Funding Rounds & Investors (9)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Convertible Note | •••••• | 3 |
|
05 Jan 2023 |
| Secondary Market | •••••• | 1 |
|
18 Jan 2021 |
| Venture Round | •••••• | 2 |
|
12 Dec 2017 |
| Series C | •••••• | 6 |
|
19 May 2015 |
| Grant | •••••• | - | 16 Jan 2013 |
Akamis Bio Alternatives & Competitors
Akamis Bio vs
iTeos Therapeutics
United States
Cancer Immunotherapies by Design
Post Ipo Equity
186 employees
Biotechnology, Health Care
Akamis Bio vs
Apexigen
United States
Creating Transformative Immunotherapies for Patients with Cancer
Post Ipo Equity
11 employees
Biopharma, Biotechnology
Akamis Bio vs
FAQ About Akamis Bio
Harnessing the Power of Tumor Gene Therapy to Turn the Tide in the Battle Against Cancer
Akamis Bio was founded in 2010.
Akamis Bio is headquartered in Abingdon, United Kingdom.
Akamis Bio operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Akamis Bio has approximately 50 employees.
Akamis Bio has completed 9 funding rounds, raising a total of $102.70M. The latest funding stage is Convertible Note.
Top alternatives and competitors to Akamis Bio include iTeos Therapeutics, Apexigen, OncoResponse, Cothera Bioscience, Aurora Oncology. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Akamis Bio and iTeos Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors Akamis Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.
